
This episode discusses advancements in brain-computer interfaces and AI-driven drug discovery, highlighting a study on neurofeedback training and Isomorphic Labs' funding success.
The provided sources detail cutting-edge developments in HealthTech , focusing on advancements in brain-computer interfaces (BCI) and AI-driven drug discovery . One report highlights a study where neurofeedback training allows individuals to visualize and control brain states, effectively "transferring" mental imagery practice into improved physical motor performance . Simultaneously, the text discusses Isomorphic Labs , an Alphabet subsidiary that secured $2.1 billion in funding to scale its IsoDDE engine . This AI platform significantly outperforms previous models in predicting how drug molecules bind to proteins , potentially unlocking treatments for previously unreachable diseases. Together, these sources illustrate a future where technology enhances human biology and computational intelligence reshapes the pharmaceutical industry.
Explore listener stats, chart rankings, contacts and more on the HealthTech Deep Dive podcast page.